DOXIL 2 mg/mL

DOXIL 2 mg/mL is a liposomal injection containing doxorubicin hydrochloride, used for targeted chemotherapy. This formulation is designed for intravenous administration and is supplied in single-use vials.

DOXIL 2 mg/mL is primarily used in cancer treatment, specifically for certain types of tumors. It is often prescribed for conditions where targeted chemotherapy is beneficial. The liposomal formulation aims to deliver the medication directly to the affected areas, potentially reducing side effects compared to conventional doxorubicin.

Common effects of DOXIL 2 mg/mL may include fatigue, nausea, and changes in skin color. Some patients may experience hand-foot syndrome, characterized by redness, swelling, or peeling of the skin on the palms and soles. These effects can vary among individuals and should be discussed with a healthcare provider.

DOXIL 2 mg/mL should be handled with care, as it is a potent medication. It is important to follow proper storage and administration guidelines to ensure safety. Patients should be monitored for signs of infusion reactions, which can include fever, chills, or shortness of breath. Always consult a healthcare professional for personalized advice.

DOXIL 2 mg/mL may interact with other medications, including those that affect liver function or blood cell production. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy and safety of this medication.